English
Bl-innovazzjoni kontinwa u l-iżvilupp mgħaġġel tal-bijoteknoloġija, il-mediċina riġenerattiva u t-terapija taċ-ċelluli esperjenzaw tkabbir splussiv, u t-teknoloġija tal-kultura taċ-ċelluli fuq skala kbira kompliet timmatura. Fost dawn, il-Fost ħafna metodi ta 'kultura fuq skala kbira, fabbriki taċ-ċelluli għandhom il- karatteristiċi tal-iffrankar tal-ispazju, it-tnaqqis tal-input tax-xogħol, u l-evitar tat-tniġġis, u huma gradwalment iffavoriti minn istituzzjonijiet ta 'riċerka xjentifika u kumpaniji farmaċewtiċi. Ġeneralment, il-produzzjoni fuq skala kbira fil-fabbriki taċ-ċelluli teħtieġ l-għajnuna ta 'shaker. Dan għaliex hemm ħafna saffi ta 'kontenituri fil-kultura fuq skala kbira. L-użu ta 'shaker jista' jirrealizza l-awtomazzjoni ta 'operazzjonijiet bħal għalf likwidu, taħlit taċ-ċelluli, u diġestjoni u effluwent waqt il-kultura. u effiċjenza għolja, tnaqqas l-iżbalji kkawżati minn operazzjonijiet manwali tqal u fatturi umani. huwa konsumabbli użat komunement f'kultura taċ-ċelluli fuq skala kbira, u dan il-metodu ta 'kultura taċ-ċelluli ġeneralment jeħtieġ l-għajnuna ta' shaker. jinkludu CHO, Vero, MRC-5, 2BS, 293T, L929 u ċelluli diploid umani. Dawn iċ-ċelloli jintużaw prinċipalment fl-eritropojetin, preparazzjoni ta 'antikorpi monoklonali, produzzjoni ta' vaċċin u prodotti oħra. Il-kultura fuq skala kbira ta 'ċelluli ta' l-annimali in vitro teħtieġ produzzjoni tal-massa ta 'densità għolja f'kontenituri tal-kultura taċ-ċelluli taħt il-kondizzjonijiet ta' temperatura, umdità, pH u ossiġnu maħlul artifiċjalment stabbiliti.
Barra minn hekk, l-użu ta 'shaker jista' jkollu rwol fit-trasferiment tal-massa, li jwassal għat-teħid ta 'kampjuni u d-determinazzjoni ta' parametri differenti. Għalhekk, meta tuża fabbriki taċ-ċelluli għal kultura fuq skala kbira, ċekċieka ġeneralment tintuża biex ittejjeb l-effiċjenza tal-kultura u tiżgura l-progress bla xkiel tal-kultura taċ-ċelluli.
Among many large-scale culture methods, cell factories have the characteristics of saving space, reducing labor input, and avoiding pollution, and are gradually favored by scientific research institutions and pharmaceutical companies. Generally, large-scale production in cell factories requires the help of a shaker. This is because there are many layers of containers in large-scale culture. Using a shaker can realize the automation of operations such as liquid feeding, cell mixing, and digestion and effluent during culture. and high efficiency, reducing errors caused by heavy manual operations and human factors.
In addition, the use of a shaker can play a role in mass transfer, which is conducive to the sampling and determination of different parameters. Therefore, when using cell factories for large-scale culture, a shaker is generally used to improve the culture efficiency and ensure the smooth progress of cell culture.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.